Related Experiment Video
Updated: Jan 21, 2026

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
Published on: November 13, 2012
The thioredoxin system and cancer therapy: a review
Fariba Mohammadi1,2, Arash Soltani1,2, Atefeh Ghahremanloo1
1Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:
Thioredoxin (Trx), thioredoxin reductase (TrxR), and NADPH are key members of the Trx system that is involved in redox regulation and antioxidant defense. In recent years, several researchers have provided information about the roles of the Trx system in cancer development and progression. These reports indicated that many tumor cells express high levels of Trx and TrxR, which can be responsible for drug resistance in tumorigenesis. Inhibition of the Trx system may thus contribute to cancer therapy and improving chemotherapeutic agents. There are now a number of effective natural and synthetic inhibitors with chemotherapy applications possessing antitumor activity ranging from oxidative stress induction to apoptosis. In this article, we first described the features and functions of the Trx system and then reviewed briefly its correlations with cancer. Finally, we summarized the present knowledge about the Trx/TrxR inhibitors as anticancer drugs.
Insights
The thioredoxin (Trx) system aids cancer progression and drug resistance. Inhibiting Trx/TrxR shows promise as an anticancer strategy, offering new therapeutic avenues.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- The thioredoxin (Trx) system, comprising Trx, TrxR, and NADPH, is crucial for redox regulation and antioxidant defense.
- Elevated Trx and TrxR levels are observed in many tumor cells, contributing to tumorigenesis and chemoresistance.
Purpose of the Study:
- To review the features and functions of the Trx system.
- To explore the correlation between the Trx system and cancer development.
- To summarize current knowledge on Trx/TrxR inhibitors as potential anticancer drugs.
Main Methods:
- Literature review of the Trx system's role in cancer.
- Analysis of Trx/TrxR expression in tumor cells.
- Summary of natural and synthetic Trx/TrxR inhibitors.
Main Results:
- The Trx system plays a significant role in cancer progression and drug resistance.
- Inhibition of the Trx system can induce oxidative stress and apoptosis in cancer cells.
- Various natural and synthetic compounds exhibit antitumor activity by targeting the Trx system.
Conclusions:
- Targeting the Trx system presents a viable strategy for cancer therapy.
- Trx/TrxR inhibitors hold potential as novel chemotherapeutic agents.
- Further research into Trx/TrxR inhibitors could lead to improved cancer treatments.
More Related Videos
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
10:51Protocols for Assessing Radiofrequency Interactions with Gold Nanoparticles and Biological Systems for Non-invasive Hyperthermia Cancer Therapy
Published on: August 28, 2013
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Gene Therapy
Group Therapy